KMPHARMACEUTICAL Co.,Ltd. (KOSDAQ:225430)
South Korea · Delayed Price · Currency is KRW 698.00
+16.00 (2.35%)
At close: Sep 14, 2026
KMPHARMACEUTICAL Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 16,975 | 15,990 | 14,475 | 17,770 | 15,631 | 22,705 |
Revenue Growth | 21.12% | 10.47% | -18.54% | 13.68% | -31.16% | -0.97% |
Gross Profit Gross Profit Growth | 3,777 | 3,838 | 3,606 | 4,910 | 3,225 | 5,663 |
Operating Income Operating Income Growth | -3,596 | -3,552 | -3,848 | -1,113 | -3,722 | 866.14 |
Net Income Net Income Growth | -3,771 | -3,968 | -4,573 | -1,320 | -3,925 | -611.19 |
Earnings Per Share EPS Growth | -135.21 | -142.29 | -164.00 | -47.00 | -141.00 | -22.00 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Household Goods and Quasi-drugs Product Household Goods and Quasi-drugs Product Growth | 13,679 | 16,686 | 14,967 | 22,069 | 21,606 |
Household Goods and Quasi-drugs Merchandise Household Goods and Quasi-drugs Merchandise Growth | 383.04 | 361.36 | 254.52 | 373.02 | 1,149 |
Toll Processing Toll Processing Growth | 23.19 | - | - | - | - |
Other Other Growth | 389.41 | 721.87 | 410.36 | 263.09 | 172.21 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 138.4 | 350.62 | 809.97 | 1,024 | 597.75 | 2,697 |
Total Debt Total Debt Growth | 18,670 | 15,800 | 14,136 | 12,447 | 13,268 | 9,681 |
Net Cash (Debt) Net Cash Growth | -18,532 | -15,449 | -13,326 | -11,423 | -12,671 | -6,985 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -664.44 | -554.00 | -477.87 | -406.72 | -455.17 | -251.42 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -2,575 | -1,751 | -2,036 | 1,446 | -93.32 | 2,267 |
Capital Expenditures CapEx Growth | -1,252 | -258.11 | -365.1 | -112.77 | -57.69 | -2,365 |
Free Cash Flow Free Cash Flow Growth | -3,827 | -2,009 | -2,401 | 1,333 | -151.02 | -97.92 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 22.25% | 24.00% | 24.91% | 27.63% | 20.63% | 24.94% |
Operating Margin | -21.19% | -22.21% | -26.58% | -6.26% | -23.81% | 3.82% |
Pretax Margin | -21.72% | -24.29% | -29.36% | -5.42% | -29.26% | -2.26% |
Profit Margin | -22.22% | -24.82% | -31.60% | -7.43% | -25.11% | -2.69% |
FCF Margin | -22.55% | -12.56% | -16.59% | 7.50% | -0.97% | -0.43% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
P/FCF Ratio | - | - | - | 20.45 | - | - |
PS Ratio | 0.23 | 0.94 | 1.32 | 1.54 | 2.84 | 2.73 |